539 related articles for article (PubMed ID: 16466842)
1. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.
Hack CE
Toxicology; 2006 Apr; 221(2-3):241-8. PubMed ID: 16466842
[TBL] [Abstract][Full Text] [Related]
2. Data cloning: easy maximum likelihood estimation for complex ecological models using Bayesian Markov chain Monte Carlo methods.
Lele SR; Dennis B; Lutscher F
Ecol Lett; 2007 Jul; 10(7):551-63. PubMed ID: 17542934
[TBL] [Abstract][Full Text] [Related]
3. Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
de Gunst MC; Dewanji A; Luebeck EG
Stat Med; 2003 May; 22(10):1691-707. PubMed ID: 12720305
[TBL] [Abstract][Full Text] [Related]
4. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
Mörk AK; Jonsson F; Johanson G
Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
[TBL] [Abstract][Full Text] [Related]
5. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
Hack CE; Chiu WA; Jay Zhao Q; Clewell HJ
Regul Toxicol Pharmacol; 2006 Oct; 46(1):63-83. PubMed ID: 16889879
[TBL] [Abstract][Full Text] [Related]
6. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
Allen BC; Hack CE; Clewell HJ
Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
[TBL] [Abstract][Full Text] [Related]
7. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
[TBL] [Abstract][Full Text] [Related]
8. A Metropolis Monte Carlo implementation of bayesian time-domain parameter estimation: application to coupling constant estimation from antiphase multiplets.
Andrec M; Prestegard JH
J Magn Reson; 1998 Feb; 130(2):217-32. PubMed ID: 9500892
[TBL] [Abstract][Full Text] [Related]
9. A gradient Markov chain Monte Carlo algorithm for computing multivariate maximum likelihood estimates and posterior distributions: mixture dose-response assessment.
Li R; Englehardt JD; Li X
Risk Anal; 2012 Feb; 32(2):345-59. PubMed ID: 21906114
[TBL] [Abstract][Full Text] [Related]
10. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
[TBL] [Abstract][Full Text] [Related]
11. Exploring fast computational strategies for probabilistic phylogenetic analysis.
Rodrigue N; Philippe H; Lartillot N
Syst Biol; 2007 Oct; 56(5):711-26. PubMed ID: 17849326
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian approach to parameter estimation in HIV dynamical models.
Putter H; Heisterkamp SH; Lange JM; de Wolf F
Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633
[TBL] [Abstract][Full Text] [Related]
13. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
Wong MC; Lam KF; Lo EC
Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo method for calculating Bayesian uncertainties in internal dosimetry.
Puncher M; Birchall A
Radiat Prot Dosimetry; 2008; 132(1):1-12. PubMed ID: 18806256
[TBL] [Abstract][Full Text] [Related]
15. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.
Jonsson F; Johanson G
Toxicol Appl Pharmacol; 2002 Feb; 179(1):35-49. PubMed ID: 11884235
[TBL] [Abstract][Full Text] [Related]
17. Towards quantitative uncertainty assessment for cancer risks: central estimates and probability distributions of risk in dose-response modeling.
Kopylev L; Chen C; White P
Regul Toxicol Pharmacol; 2007 Dec; 49(3):203-7. PubMed ID: 17905499
[TBL] [Abstract][Full Text] [Related]
18. MCMC for hidden Markov models incorporating aggregation of states and filtering.
Rosales RA
Bull Math Biol; 2004 Sep; 66(5):1173-99. PubMed ID: 15294422
[TBL] [Abstract][Full Text] [Related]
19. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
Jordan P; Brunschwig H; Luedin E
Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
[TBL] [Abstract][Full Text] [Related]
20. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.
Chiu WA; Okino MS; Evans MV
Toxicol Appl Pharmacol; 2009 Nov; 241(1):36-60. PubMed ID: 19660485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
